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Summary
The factors regulating dendritic cell (DC) develop-
ment and homeostasis are incompletely understood.
Here, we demonstrate that DCs express the lympho-
toxin (LT)- receptor (LTR) and that in mice lacking
the LTR in hematopoietic cells, spleen, and lymph
node, CD8− DC numbers are reduced. B cells are a
key source of LT12 for splenic DC homeostasis,
and transgenic overexpression of LT12 on B cells
leads to expansion of the CD8− DC compartment. Fur-
thermore, we find that about 5% of splenic DCs are
undergoing cell division, and the number of dividing
CD8− DCs is disproportionately reduced in the ab-
sence of the LTR. In parabiosis experiments, splenic
DCs were only partially replaced by circulating pre-
cursors over a 6 week period. We conclude that
LT12 acts on DCs or DC precursors to promote DC
homeostasis, and we suggest that DC proliferation is
an important pathway for locally maintaining these
cells in the steady state.
Introduction
DCs within secondary lymphoid tissues are important
for induction of adaptive immunity and for T cell ho-
meostasis and tolerance. The spleen contains three major
DC populations, often identified by their differential ex-
pression of CD4 and CD8, all of which express high
amounts of CD11c. During homeostasis, CD4+CD8−
and CD4−CD8− DCs, also referred to as “myeloid” DCs,
are found predominantly in the splenic marginal zone
and marginal zone bridging regions, whereas CD4−CD8+
“lymphoid” DCs are enriched in the T zone (Ardavin,
2003). Lymph nodes contain additional DCs that ex-
press high amounts of MHC class II and are derived
from peripheral tissues via lymphatic vessels (Ardavin,
2003; Shortman and Liu, 2002). DCs in the blood have*Correspondence: cyster@itsa.ucsf.edu
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10021.a distinct phenotype from the major lymphoid tissue
DC populations and are identified as CD11clo and MHC
class IIhi or class IIlo. An additional DC subset, known
as plasmacytoid DCs, expresses low levels of CD11c
and B220 and is present in lymphoid tissues and blood
(Ardavin, 2003; Shortman and Liu, 2002).
Lymphoid tissue DCs have a short life span, with
50% turnover times of splenic CD4+8−, CD4−8−, and
CD4−8+ DCs estimated as 2.9, 2.0, and 1.5 days,
respectively (Kamath et al., 2002; Kamath et al., 2000;
Ruedl et al., 2000). The equivalent DC subsets within
lymph nodes also turnover rapidly, whereas DCs de-
rived from the skin exhibit a lag phase in bromodeoxy-
uridine (BrdU) incorporation and take more than 1 week
to achieve 50% labeling (Kamath et al., 2002; Ruedl et
al., 2000). Despite the very rapid turnover of lymphoid
tissue DCs, the immediate precursors of these cells
and the factors involved in their homeostasis within
lymphoid tissues are not well understood. Although
common lymphoid and common myeloid progenitors,
bone marrow DCs, blood DCs, and blood monocytes
can all give rise to lymphoid tissue DCs in transfer ex-
periments, it has not been established whether these
cells are the immediate precursors involved in main-
taining lymphoid tissue DCs under conditions of ho-
meostasis (Diao et al., 2004; Leon et al., 2004; Manz et
al., 2001).
The Fms-like tyrosine kinase (Flt)-3 is expressed by
common lymphoid and common myeloid progenitors
and is thought to be required for DC differentiation in
the bone marrow (Karsunky et al., 2003). The TNF-related,
activation-induced cytokine (TRANCE) receptor is ex-
pressed by DCs, and treatment with TRANCE can en-
hance DC survival (Josien et al., 2000). However,
TRANCE-deficient mice have not been reported to suf-
fer a DC deficiency (Kong et al., 1999). Mice lacking
TNF receptor associated factor (TRAF)-6 are deficient
in CD4+8− DCs, and this has been suggested to reflect
the role of this signaling molecule downstream of CD40
and TLRs, though homeostatic DC deficiencies have
not been reported in mice lacking CD40 or individual
TLRs (Ardavin, 2003; Kobayashi et al., 2003). Mice defi-
cient in a further TNF receptor family member, LTβR, or
its membrane-associated ligand, LTα1β2, do exhibit a
DC deficiency (Abe et al., 2003; Berger et al., 1999; Wang
et al., 2002; Wu et al., 1999). However, this deficiency
has been suggested to be secondary to defective DC
recruitment or retention because of the important role
played by LTα1β2 in promoting chemokine and adhe-
sion molecule expression by lymphoid stromal cells
(Abe et al., 2003; Wu et al., 1999). Therefore, the factors
involved in maintaining homeostasis of rapidly turning
over lymphoid tissue DCs have been unclear.
Here, we have questioned the notion that splenic DC
deficiency in mice lacking LTα/β or LTβR is due solely
to defective DC homing, because mice deficient in T
zone chemokines have not been found to have a sple-
nic DC deficiency (Gunn et al., 1999). Instead, we have
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440Figure 1. Enumeration of DC Subsets in Mice Lacking LTβR on Hematopoietic Cells
(A) Flow cytometric analysis of CD4 and CD8 expression on CD45.2+CD11c+ DCs in LTβR+/+ bone marrow chimeras (top), LTβR−/− bone
marrow chimeras (middle), and LTβR−/− mice (bottom). Boxes demarcate CD45.2+CD11c+ (left) and CD4+CD8−, CD4−CD8−, and CD4−CD8+
subsets (right), and numbers indicate the percentage of total cells.
(B) Mean number of DCs of the indicated type per spleen from LTβR+/+ and LTβR−/− bone marrow chimeras, LTβR−/−, and LTα−/− mice.
Plasmacytoid DCs (pDCs) were defined as CD11cint CD19− B220+ cells.
(C) Spleen sections from LTβR+/+ and LTβR−/− bone marrow chimeras were stained to detect CD11c+ DCs (blue). White-pulp cords were
identified by staining for MAdCAM-1 (brown), a marker of marginal sinus cells. Objective magnification, 5×.
(D) Quantitative PCR analysis of the indicated chemokines in total spleen tissue from LTβR+/+ and LTβR−/− bone marrow chimeras and LTβR−/−
mice expressed as relative amount of indicated messenger RNA normalized to hypoxanthine phosphoribosyl transferase (HPRT).
(E) Number of DCs of the indicated types in peripheral lymph nodes from LTβR+/+ and LTβR−/− bone marrow chimeras. MHC class IIhi skin-
derived DCs are subdivided into DEC205hi epidermal Langerhans cells and DEC205lo dermal DCs. pDCs were identified as in (B).
(F) Frequency of CD11cint NK1.1− MHC class IIhi and MHC class IIlo DCs, Ly6Chi CD11b+ monocytes (mono), and Ly6Cint CD11b+ neutrophils
(neu) in the blood (left), and the number of CD11c+ cells per liver and lung (right) from LTβR+/+ and LTβR−/− bone marrow chimeras are shown.
For details on gating, see Figure S2. Bars show the mean ± SD from at least three mice per group, and the data are representative of three
experiments, except for the quantitative PCR analysis where relative amounts are the average values pooled from two separate experiments.
A Student’s t test was performed between the indicated groups and an asterisk indicates p < 0.05.
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441investigated the hypothesis that LTα1β2 is a DC growth
or survival factor.
Results
Intrinsic LTR Requirement for DC Homeostasis
To test whether the DC deficiency in LT-deficient mice
was due to a requirement for LTβR within hematopoi-
etic cells, lethally irradiated wild-type (wt) CD45.1 mice
were reconstituted with LTβR-deficient or wt CD45.2
bone marrow cells for 6 weeks. Compared to the wt
control chimeras, mice reconstituted with LTβR-defi-
cient bone marrow exhibited a deficiency in the number
of CD4+CD8− and CD4−CD8− DCs, whereas CD4−CD8+
DCs were not affected (Figures 1A and 1B). The extent
of DC deficiency was similar to that seen in mice con-
genically deficient in LTβR or in mice lacking LTα and
therefore deficient in the LTβR ligand LTα1β2 (Figures
1A and 1B). Splenic DC numbers were similarly reduced
in LTβ−/− mice (data not shown). CD11cint CD19− B220+
plasmacytoid DCs were also enumerated, and a mild
reduction was detected in the LTβR−/− bone marrow
chimeras, but not in LTβR−/− mice. By immunohisto-
chemical analysis, mice reconstituted with wt bone
marrow contained large numbers of CD11c+ DCs within
the splenic marginal zone, bridging zones, and red pulp
(Figure 1C, left). By contrast, in mice reconstituted with
LTβR-deficient bone marrow, the frequency of CD11c+
DCs in these areas was reduced, whereas DC numbers
in the T zone areas appeared little affected (Figure 1C,
right). Hematopoietic LTβR deficiency did not affect
lymphoid chemokine expression in the spleen (Figure
1D), consistent with previous studies showing that the
major CCL19-, CCL21-, and CXCL13-producing cells
within the spleen are radiation-resistant stromal cells
(Ansel et al., 2002; Luther et al., 2000). Moreover, analy-
sis of spleens from plt/plt mice confirmed that DC num-
bers were in the normal range despite the CCR7 ligand
deficiency in these mice (Figure S1 available in the Sup-
plemental Data online with this article). Reductions in
CD4+CD8− and CD4−CD8− DCs were also detected in
lymph nodes of LTβR−/− bone marrow chimeras, though
these decreases were less severe than in the spleen.
Skin-derived CD11cint MHC class IIhi DEC205lo DCs
were mildly reduced in cell number (Figure 1E). The fre-
quencies of circulating CD11cint MHC class IIhi DCs and
CD11cint MHC class IIlo DCs, as well as monocytes and
neutrophils, were not affected by LTβR deficiency (Fig-
ure 1F). Analysis of immature DCs in lungs and liver
revealed that numbers were slightly reduced, indicating
that the LTβR requirement in DCs may extend beyond
lymphoid tissues. However, as LTβR deficiency had the
most marked effect on lymphoid tissue DCs, we fo-
cused on these cells for the remainder of this study.
Although the above findings indicated that homeo-
stasis of CD8− DCs within lymphoid tissues was depen-
dent on LTβR expression within hematopoietic cells
rather than in stromal cells, they did not establish
whether the receptor requirement was intrinsic to DCs.
To further test this possibility and to also examine
whether LTβR−/− DCs had reduced competitiveness for
contributing to the DC compartment, irradiated CD45.1Figure 2. Intrinsic Requirement of LTβR Signaling for DC Homeo-
stasis
(A) Irradiated CD45.1 mice were reconstituted with an equal mixture
of CD45.1 wild-type (wt) cells and CD45.2 LTβR−/− cells. Top panels:
flow cytometric analysis of CD11c expression among CD45.2− wt
and CD45.2+ LTβR−/− splenocytes and lymph node cells. Bottom
panels: CD4 and CD8 expression on CD45.2− wt and CD45.2+
LTβR−/− CD11c+ DCs in spleen.
(B) Ratio of CD45.2+ LTβR−/− DC subsets and Gr-1+ cells compared
to CD45.2− wt cells. Differences in reconstitution efficiencies be-
tween experiments were normalized by determining the ratio of
CD19+ CD45.2 and CD45.1 B cells and adjusting this ratio to 1.
Bars represent mean ± SD for eight mice. Data are compiled from
four experiments. All LTβR−/− DC subsets in spleen and lymph
nodes were significantly underrepresented compared to the fre-
quency expected based on the input cell ratios (p < 0.05).mice were reconstituted with a mixture of CD45.1 wt
and CD45.2 LTβR−/− bone marrow cells. Analysis after 6
weeks showed that LTβR−/− CD4+CD8− and CD4−CD8−
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DCs were reduced in frequency in both spleen and w
lymph nodes to a greater extent than in the 100% C
LTβR−/− bone marrow chimeras (Figures 2A and 2B). L
Furthermore, the LTβR−/− CD4−CD8+ DCs were also a
underrepresented in the mixed chimeras, whereas C
LTβR−/− bone marrow cells generated granulocytes and
lymphocytes with equal efficiency to wt bone marrow L
cells (Figure 2 and data not shown). These results indi- t
cate that the LTβR is required intrinsically within DCs T
or DC precursors for normal accumulation of lymphoid a
tissue DCs during homeostasis. The greater deficiency m
of LTβR−/− DCs in the mixed bone marrow chimeras c
than in 100% LTβR−/− bone marrow chimeras suggests m
that the defect in LTβR-deficient DCs or DC precursors s
is more prominent when the cells have to compete with o
wt cells. s
In agreement with these functional studies showing C
a requirement for the LTβR within DCs, abundant 3
amounts of the LTβR were detected on splenic (
CD4+CD8−, CD4−CD8−, and CD4−CD8+ DCs, whereas e
tlymphocytes lacked receptor expression (Figure 3A).Q
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(A) FACS analysis of LTβR expression on splenic CD4+8−, CD4−8−, c
and CD4−8+ CD11c+ DCs, CD3+ T cells, and CD19+ B cells from
SLTβR−/− (dashed line), LTβR+/+ (solid line), and LTβ−/− (bold line)
wmice. The data are representative of three experiments.
T(B) Quantitative PCR analysis of LTβR in splenic CD4+8−, CD4−8−,
Cand CD4−8+ CD11c+ DC subsets, CD3+ T cells, and CD19+ B cells
from B6 mice, expressed as relative amount of the indicated mes- n
senger RNA normalized to HPRT. The relative amounts are the a
average values pooled from two separate experiments. tuantitative PCR analysis confirmed that each splenic
C type expressed the LTβR (Figure 3B). When cells
rom the spleens of LTα- or LTβ-deficient mice were
nalyzed, CD4+CD8− and CD4−CD8− DCs, but not
D4−CD8+ DCs, showed greater LTβR staining than
ells from wt mice (Figure 3A and data not shown).
TβR expression was also detected in monocytes and
lood DCs, though in these cases, receptor levels were
ot elevated on cells taken from LTα-deficient mice
Figure S2). These observations suggest that under
onditions of homeostasis, CD8− DC are encountering
Tα1β2 and undergoing receptor downmodulation,
hereas other DC types are not encountering sufficient
igand to cause receptor downmodulation.
Cells Are a Source of LT12 for DC Homeostasis
ecause B cell-deficient mice have reduced numbers
f splenic DCs (Crowley et al., 1999; Ngo et al., 2001)
nd B cells express LTα1β2 (Ansel et al., 2000), we
ested whether the role of B cells in DC homeostasis
as to act as a source of this membrane cytokine. Le-
hally irradiated wt mice were reconstituted with a mix-
ure containing 70% B cell receptor deficient (MT)
one marrow and 30% LTα−/− bone marrow as a
ethod to generate mice where the majority of cells
ere wt but all the B cells were LTα deficient. Control
ice were reconstituted with 70% MT and 30% wt
one marrow or with 100% LTα+/+ or LTα−/− bone mar-
ow. As previously observed, LTα−/− and MT mice
howed a marked deficiency of CD4+CD8− splenic DCs,
hereas T cell-deficient mice contained normal num-
ers of DCs (Figure 4A). In mice where all the B cells
ere LTα deficient, there was a marked DC deficiency,
imilar to that observed in mice that were 100% defi-
ient in LTα in bone marrow-derived cells (Figure 4A).
imilar findings were made for CD4−CD8− DCs,
hereas CD4−CD8+ DCs were not affected by B cell or
cell deficiency (data not shown). The deficiencies in
D8− DCs in the mixed bone marrow chimeras were
ot due to reductions in B cell production, as these
nimals contained normal numbers of B cells, and con-
rol MT-wt-mixed bone marrow chimeras contained
imilar numbers of DCs as mice reconstituted purely
ith wt bone marrow (Figure 4A and data not shown).
onsistent with B cells acting as a source of membrane
Tα1β2 for DCs, many DCs in the splenic marginal zone
nd bridging zone regions were in close contact with
D19+ B lymphocytes (Figure 4B).
T12 Overexpression on B Cells Leads
o an Expansion in Splenic DC Numbers
o test whether LTα1β2 was sufficient to promote DC
ccumulation in vivo, we examined DC frequencies in
ice transgenic for a transmembrane bound LTα mole-
ule under control of Ig κ enhancer and promoter ele-
ents. Two transgenic lines were examined, both
howing overexpression of LTα1β2 on B cells, but not
n T cells (Figure 5A) or on myeloid cells (data not
hown). In these animals, the number of splenic
D4+CD8− and CD4−CD8− DCs was increased 2- to
-fold, whereas CD8+ DC numbers were little affected
Figure 5B, left). Similar findings were made in periph-
ral lymph nodes (4.8 ± 1.1 × 104 CD4+CD8− DCs in LTα
ransgenics versus 3.3 ± 0.8 × 104 in littermate controls,
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443Figure 4. B Cells as a Critical Source of LTα1β2 for DC Homeostasis
(A) The number of splenic CD4+8− CD11c+ DCs in wt, TCRβ−/−δ−/−
(TCR−/−), MT (BCR−/−), or bone marrow chimeric mice. Chimeric
mice were generated by reconstituting lethally irradiated wt mice
with a mixture of 70% BCR−/− bone marrow and 30% LTα−/− or wt
(LTα+/+) bone marrow or with 100% LTα+/+ or LTα−/− bone marrow.
Bars show the mean ± SD from at least four mice per group, and
the data are representative of three experiments. A student’s t test
was performed between the indicated groups and an asterisk indi-
cates p < 0.05.
(B) Interaction between B cells and DCs in vivo. Spleen sections
from B6 mice were stained to detect CD11c+ DCs and CD19+ B
cells. Objective magnification, 5× (left) and 20× (right).n = 5, p < 0.05). Total cell numbers and B cell numbers
in the spleen were not affected by LTα overexpression
(Figure 5B, right), and immunohistochemical analysis
revealed that B cell distribution within transgenic
spleens was normal, whereas CD11c staining was in-
creased (Figure 5C).
LTR Engagement Promotes Accumulation
of Mature DCs in Bone Marrow-Derived
Dendritic Cell Cultures
As a further approach to test whether LTβR signaling
could promote the development or accumulation of
DCs, we treated bone marrow-derived DC cultures with
an agonistic anti-LTβR antibody (Dejardin et al., 2002).
In the presence of granulocyte macrophage colony-
stimulating factor (GM-CSF), one day of agonist treat-
ment caused a 2-fold increase in the accumulation of
mature CD11c+ MHC class IIhi DCs in wt cultures,
whereas it had no effect in LTβR−/− cultures (Figure 5D).
There was little change in the total number of CD11c+cells in these cultures, suggesting that agonist treat-
ment promoted maturation of MHC class IIhi DCs from
CD11c+ MHC class IIlo immature cells. Because GM-
CSF is not required for the development of DCs under
conditions of homeostasis in vivo (Ardavin, 2003), we
also tested the effect of 1 day LTβR-agonist treatment
in the absence of GM-CSF. In these cultures, there was
a 40% increase in the total number of CD11c+ cells,
compared to untreated cultures (Figure 5E, p < 0.02),
as well as an increase in the fraction of the DCs that
were mature MHC class IIhi cells, indicating that LTβR
engagement in bone marrow-derived dendritic cell
(BMDC) cultures can promote DC development or
maintenance as well as maturation.
Detection of Dividing DCs in the Spleen and Their
Reduction in LTR-Deficient Mice
To determine whether the reduced DC number in LTβR-
deficient bone marrow chimeras was due to decreased
DC survival, we measured the frequency of cells incor-
porating BrdU over a 48 hr period. Rather than showing
an increased rate of BrdU incorporation that would
be consistent with increased turnover and therefore
shorter lifespan, LTβR−/− DCs incorporated BrdU at a
reduced rate, with 30% of the cells becoming BrdU la-
beled rather than 45%, indicating that the population
was turning over more slowly (Figures 6A and 6B, left).
These findings suggested that the LTβR was not func-
tioning to promote the survival of mature DCs and in-
stead that the precursor for splenic CD8− DCs was de-
pendent on LTβR signaling for production of normal
numbers of DCs. The immediate precursor for CD8−
splenic DCs has not been defined, but because DCs
themselves express the LTβR, we examined whether
these cells might renew themselves locally. After a 3.5
hr BrdU-labeling period, 5%–10% of splenic CD8− DCs
incorporated BrdU, indicating that a substantial num-
ber of splenic DCs are dividing. Importantly, not only
was the absolute number of dividing DCs decreased in
LTβR−/− bone marrow chimeras but also the fraction of
the DC population that was dividing was decreased
(Figure 6B). 5%–10% of CD8+ DCs became labeled with
BrdU in 3.5 hr, but consistent with LTα1β2 not being
essential for maintenance of this cell population, the
frequency of dividing CD8+ DCs was not affected by
LTβR deficiency (Figure 6B). In experiments with non-
chimeric B6 mice, 5.8% ± 1.7% of CD8− DCs and
5.9% ± 1.0% of CD8+ DCs (n = 11) became labeled in
3.5 hr, and similar findings were made when DCs were
preenriched by isolation on a density gradient prior to
flow cytometric analysis (data not shown). All the
CD11chi cells examined in these experiments also ex-
pressed MHC class II, and cells with the highest
amounts of MHC class II incorporated BrdU to a similar
extent as the total CD11chi population (Figure S3). Sple-
nic T cells were used as a negative control, as there is
a several day lag period between precursor division in
the thymus and T cell appearance in the periphery
(Tough and Sprent, 1994), and few of these cells were
labeled in 3.5 hr (Figure 6B). Immunohistochemical
staining of spleen tissue from mice treated with BrdU
for 3.5 hr revealed BrdU+ CD11c+ cells in the marginal
zone and red pulp (Figure 6C), providing a confirmation
of the flow cytometric data.
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444Figure 5. Increased CD8− DCs in Mice Overexpressing LTα1β2 on B Cells and Increased DC Numbers in BMDC Cultures Treated with Agonistic
LTβR Antibody
(A) Flow cytometric profiles of LTα expression on CD19+ B and CD3+ T cells from spleens of wt (dashed line), LTα transgenic (tg) line β10
(solid line), and LTα tg line β4 (bold line) mice using LTβR-Ig binding.
(B) The number of CD4+8−, CD4−8−, CD4−8+ CD11c+ DCs (left), total splenocytes, and B220+ cells (right) in nontransgenic (wt) and LTα
transgenic (tg) line β4 and β10 mice. Bars represent the mean number of DCs ± SD of the indicated subsets and are from values pooled from
two experiments.
(C) Immunohistochemical analysis of spleen sections from wt and LTα tg (line β4) mice stained to detect B cells (B220, brown) and DCs
(CD11c, blue).
(D and E) Numbers of total CD11c+ cells and CD11c+ MHC class IIhi DCs in 5 day BMDC cultures incubated for a further day in the absence
(control) or presence of an anti-LTβR agonistic antibody and with (D) or without (E) GM-CSF. In some experiments, purified GM-CSF was
used ([D], left), and in others, GM-CSF containing 3T3 cell culture supernatant ([D], right) with similar results. Bars in (D), left, and (E) show
the mean ± SD from five mice per group and an asterisk indicates p < 0.05 (Student’s t test). Data points in (D), right, represent individual
mice, and bars represent the mean values; these data are from one experiment that is representative of three.As a further approach to measure cell division, DNA d
(content was determined in freshly isolated splenocytes
by using the DNA dye 7-aminoactinomycin D (AAD). o
DFlow cytometric analysis of 7-AAD-loaded cells re-
vealed that 4.5% of splenic CD8− DCs were in the
tS/G2/M phases of the cell cycle, and again there was
a reduction in the frequency as well as the number of tividing cells in LTβR-deficient bone marrow chimeras
Figures 6D and 6E). Reciprocally, in transgenic mice
verexpressing LTα1β2 on B cells, the number of CD8−
Cs in S/G2/M was increased (Figure 6E).
To examine whether the dividing DCs we detected in
he spleen might be derived directly from CD11c+ DCs
hat enter the spleen from the blood, we measured the
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445turnover rate of CD11cint MHC class IIhi and MHC class
IIlo DCs in blood. In contrast to the rapid turnover of
splenic DCs, relatively few blood DCs incorporated
BrdU after 48 hr, indicating that they are not being
rapidly replaced by dividing precursors in the bone
marrow and making it unlikely that they give rise di-
rectly to the BrdU-labeled DCs in the spleen (Figure
6F). Circulating granulocytes also turned over slowly,
whereas monocytes were almost 100% labeled in 48 hr
(Figure 6F), in agreement with other studies (Goto et
al., 2003).
Finally, as a further method to examine whether sple-
nic DCs were locally maintained, we measured the ex-
tent of CD8− DCs mixing between pairs of wt CD45.1
and congenic CD45.2 mice that had been surgically
joined in parabiosis. Analysis of mice that had shared
their blood supply for at least 6 weeks revealed that the
proportion of CD45.1+ B and T cells in the spleen was
equal in each partner, indicating that these recirculating
cells had reached an equilibrium distribution in the
parabiosed mice (Figure 6G) as expected (Ansel et al.,
2002). By contrast, splenic CD8− DCs failed to reach
equilibrium, with the majority of the cells in each animal
remaining of host origin (Figure 6G). This observation
indicates that splenic DCs had not all been replaced
by circulating precursors over a 6 week period and is
consistent with the conclusion that lymphoid tissue
DCs are maintained in part by local renewal.
Discussion
The above findings established that homeostasis of
CD8− lymphoid tissue DCs depends on intrinsic expres-
sion of the LTβR. B lymphocytes were shown to be an
important source of LTα1β2 for splenic DC homeosta-
sis, and overexpression of LTα1β2 under control of the
Igκ promoter and enhancer was sufficient to increase
lymphoid tissue DC numbers. During the process of in-
vestigating how LTβR signaling regulates lymphoid tis-
sue DC numbers, we found that a fraction of the
CD11c+ MHC class II+ cells within lymphoid tissues
were in cell cycle, and in the case of CD8− DCs, the
frequency of cycling cells was reduced by LTβR defi-
ciency. Furthermore, parabiosis experiments indicated
that splenic CD8− DCs failed to reach equilibrium in
mice that shared their blood circulation for more than 6
weeks. Based on these findings, we propose that
LTα1β2 promotes DC homeostasis either by helping
maintain proliferating DCs or by inducing DC develop-
ment from DC precursors within lymphoid tissues. We
suggest that DC proliferation is an important pathway
for maintaining lymphoid tissue DC numbers in the
steady state. Furthermore, LTβR signaling was found to
promote DC maturation in BMDC cultures, indicating
that the LTβR may have additional roles within DCs dur-
ing the immune response.
Although LTβR function has been most extensively
investigated in stromal cells, several early studies also
indicated expression in myeloid lineage cells (Browning
et al., 1997; Force et al., 1995). More recently, alveolar
macrophages were shown to express the receptor, and
LTβR signaling in macrophages was involved in the re-
sponse to Mycobacterium tuberculosis (Ehlers et al.,2003). Mast cells have also been shown recently to ex-
press the LTβR and stimulation via the receptor-caused
cytokine release (Stopfer et al., 2004). A previous study
suggested that mouse splenic DCs may express LTβR
(Browning and French, 2002), whereas another study
analyzing elutriated human blood DCs failed to detect
expression (Murphy et al., 1998). Here, we have demon-
strated that all splenic DC types express the LTβR. We
also detected the receptor on DCs in the blood and
on monocytes, whereas granulocytes and lymphocytes
lacked expression. Notably, the amount of LTβR stain-
ing was greater on CD8− DCs, but not CD8+ DCs or
blood DCs from mice lacking the LTβR ligand LTα1β2,
than on cells from wt mice. This might indicate that re-
ceptor levels are normally downmodulated on CD8−
DCs by ligand engagement. Alternatively, the AF.H6
anti-LTβR antibody may interact with the ligand binding
region of the receptor (Mackay et al., 1997), and anti-
body binding might therefore be reduced due to recep-
tor occupancy. Either way, this finding provides evi-
dence that many LTβRs on CD8− DCs are continually
engaged by ligand.
In previous BrdU-labeling studies, substantial num-
bers of lymphoid tissue DCs were found to incorporate
BrdU within 1 day (Kamath et al., 2000). This contrasts
with peripheral lymphocytes, which fail to incorporate
BrdU for 3 days because of the lag time associated
with precursor labeling in the bone marrow or thymus
(Tough and Sprent, 1994). Our finding that about 5% of
splenic CD11c+ MHC class II+ cells are in the S/G2/M
phases of the cell cycle provides an explanation for the
very rapid labeling kinetics of lymphoid tissue DCs.
Consistent with our results, a recent study found that
3%–10% of splenic DCs in immunized mice were in cell
cycle (Zhang et al., 2004). Circulating blood DCs incor-
porated only low amounts of BrdU over a 48 hr period,
indicating that these cells are not being replaced at the
rate of lymphoid tissue DCs and that they cannot be
directly generating all of the lymphoid tissue DCs. Al-
though blood monocytes have DC precursor potential
(Leon et al., 2004) and turn over more rapidly than
blood DCs, these cells did not label with BrdU in 3.5 hr
labeling experiments (data not shown) as expected
(Goto et al., 2003). In addition, they were not reduced
in number by LTβR deficiency, and they did not show
the evidence of LTβR engagement seen with CD8− DCs,
a combination of observations that argue against the
conclusion that monocytes continually generate all
lymphoid tissue DCs. The finding that splenic CD8−
DCs failed to equilibrate between parabiosed mice that
shared the same blood supply for more than 6 weeks
also indicated that splenic DCs are maintained at least
in part by local renewal within the tissue. To consider
whether 5% of dividing cells is sufficient to replenish
the DC compartment at a rate that can account for DC
turnover, we can consider what would happen if, in a
population of 100 cells, five cells divide every 6 hr. This
would generate 20 new cells in 24 hr or 60 cells in 3
days. That is, 5% of the cells dividing every 6 hr allows
60% of the cells to be replaced within 3 days, a turn-
over time that agrees well with the 2.9 day t1/2 for
CD4+CD8− DCs (Kamath et al., 2000). Taken together,
our findings favor the conclusion that local proliferation
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446Figure 6. Detection of Dividing DCs in the Spleen and Their Reduction in LTβR-Deficient Bone Marrow Chimeras
(A) Flow cytometric analysis of BrdU labeling among splenic CD11c+ DCs. LTβR+/+ and LTβR−/− bone marrow chimeras were treated with or
without BrdU for 48 hr, as indicated, and stained to detect CD11c and BrdU.
(B) Frequency of BrdU-positive splenic CD8− and CD8+ DCs or total CD11c+ DCs and T cells in LTβR+/+ and LTβR−/− bone marrow chimeras
treated with or without BrdU for 48 hr (left) or 3.5 hr (middle) as indicated. Plotted values represent the percentage BrdU+ cells in the indicated
population, and the data are representative of three experiments. The total number of BrdU+ cells in the 3.5 hr group is shown in the right.
Bars represent means and data points individual animals.
(C) Spleen sections from LTβR+/+ bone marrow chimeras treated with BrdU for 3.5 hr were stained to detect CD11c (blue), MAdCAM-1 (brown),
and BrdU (red). Objective magnification, 5× (left) and 20× (right). Arrow heads in the right panel indicate examples of CD11c and BrdU double-
labeled cells.
(D) DNA content of splenic CD8−CD11c+ DCs (CD8− DCs) and T cells from LTβR+/+ and LTβR−/− bone marrow chimeras examined with 7-AAD
staining. Cells in S/G2/M phases of the cell cycle are 7-AADhi, indicated by the double-headed arrow. Plotted values (right) represent the
percentage of 7-AADhi cells, and the data are pooled from three experiments.
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(E) The number of S/G2/M (7-AADhi) cells among CD8− DCs from LTβR+/+ and LTβR−/− bone marrow chimeras and LTα transgenic mice (line
β4). Bars represent means and points, individual animals.
(F) Frequency of BrdU-positive cells amongst blood cell subsets after two days of BrdU labeling. Cells analyzed were CD11cint MHC class
IIhi NK1.1− DCs, CD11cint MHC class IIlo NK1.1− DCs, Ly6Chi CD11b+ monocytes (mono), and Ly6Cint CD11b+ neutrophils (neu). Bars show the
mean ± SD from at least three mice per group, and the data are representative of three experiments.
(G) Incomplete mixing of CD8− DCs between parabiotic mice with shared blood circulation. Parabiotic pairs of wt CD45.1 and CD45.2 mice
were analyzed 8 weeks after surgical anastomosis. The mean ± SD (n = 7) percentages of CD45.1 cells in the CD45.2 partner (shaded
bars) and in the CD45.1 partner (open bars) are shown for the indicated cell types. T indicates CD8 T cells. Data are pooled from two
separate experiments.is an important mechanism contributing to lymphoid
tissue DC homeostasis.
We have not identified phenotypic differences be-
tween the dividing and nondividing DCs in the spleen,
and we therefore suggest that all lymphoid tissue DCs
may be able to divide and that only about 5% of the
cells receive the appropriate combination of stimuli to
enter cell cycle at any given time. However, it is also
possible that 5% of each of the DC subsets in the
spleen have precursor properties, dividing asymmetri-
cally to give rise to a nondividing DC and a dividing
cell with identical characteristics to the parent. Local
renewal has also been implicated in Langerhans cell
homeostasis, as these cells were shown to maintain
themselves in the skin without ongoing bone marrow
replenishment (Merad et al., 2002), and some were
found to be in metaphase (Czernielewski and De-
marchez, 1987). The possibility that the dividing lym-
phoid tissue CD11c+ MHC class II+ cells are not in-
volved in generating further DCs and instead give rise
to other cell types is considered unlikely but cannot
currently be excluded. A recent report has shown that
BMDC grown on endothelial-like splenic stroma prolif-
erate and differentiate into regulatory DCs (Shortman
and Wu, 2004; Zhang et al., 2004).
One model supported by our in vivo studies is that
LTβR engagement on lymphoid tissue CD8− DCs sup-
ports their proliferation, and when this signal is absent,
there is a reduction in the number of dividing DCs, and
as a consequence, a reduction in the total CD8− DC
population. In support of this model is the evidence that
LTβRs on splenic CD8− DCs are continually engaged by
ligand. However, although our in vitro studies with
BMDC established that CD11c+ cells can respond to
LTβR signaling, we have so far not been able to demon-
strate an effect of LTβR signaling on in vitro DC prolifer-
ation. Our findings are therefore equally consistent with
a second model where a DC precursor present within
lymphoid tissues requires LTβR signaling for efficient
development into CD8− DCs. In support of this model
is our detection of LTβR expression on all DC types,
blood DCs, and monocytes and evidence from in vitro
culture systems that the spleen contains DC precursor
potential (Wilson et al., 2000). Resolving between these
two models will be a challenge of future experiments.
In bone marrow chimeric mice that lacked the LTα
gene in all B cells but retained the gene in the majority
of cells of all other lineages, there was a splenic DC
deficiency similar to that seen in congenically LTα-defi-
cient mice, suggesting that B cells are an important
source of LTα1β2 for CD8− DC homeostasis in the
spleen. Because many CD8− DCs in spleen sections
+gagement on these cells by B cell LTα1β2 seems likely.
However, our experiments do not exclude the possi-
bility that the action of B cell LTα1β2 is indirect, for
example, leading to the recruitment of another LTα1β2+
cell type that then engages DC LTβRs. Alternatively, B
cell LTα1β2 could engage LTβRs on splenic DC precur-
sors. Mice deficient in LTα, LTβ, and LTβR were each
found to suffer a similar splenic DC deficiency, indicat-
ing that the relevant LTβR ligand is LTα1β2 and not
the alternative LTβR ligand LIGHT (Gommerman and
Browning, 2003). Although we have focused our studies
on the intrinsic role of the LTβR within DCs, the LTβR
has many functions during lymphoid organ and stromal
cell development, and certain of these extrinsic func-
tions may also be important for the development or
maintenance of lymphoid tissue DCs.
The relationship between CD4+CD8−, CD4−CD8−, and
CD4−CD8+ DCs in the spleen is still not well defined,
with some experiments suggesting that CD8+ DCs may
derive from CD4+ DCs and others arguing against this
possibility (del Hoyo et al., 2002; Naik et al., 2003). The
finding that LTβR-deficient bone marrow chimeras have
reduced numbers of CD4+ and CD4−CD8− DCs but nor-
mal numbers of CD8+ DCs disfavors the view that CD8+
DCs are derived from CD4+ DCs but is consistent with
CD4+ and CD4−CD8− DCs being closely related.
Although our findings provide evidence that local
proliferation is involved in maintaining CD8− and CD8+
lymphoid tissue DCs, circulating precursors contribute
to the long-term maintenance of lymphoid tissue DCs,
as a fraction of the DCs within the spleens of para-
biosed mice were replaced by cells of partner origin
over a 6 week period. We speculate that circulating pre-
cursors have an especially prominent role in replenish-
ing the lymphoid tissue DC compartments during im-
mune responses when many DCs are induced to
mature, just as circulating cells are involved in replen-
ishing the Langerhans cell compartment during inflam-
mation in the skin (Merad et al., 2002).
LTβR signaling in fibroblasts activates both the clas-
sical and alternative NF-κB pathways (Dejardin et al.,
2002). In fetal liver chimeras double deficient for p50
and RelA, NF-κB family members activated by the clas-
sical pathway, there are strong reductions in both CD8−
and CD8+ splenic DCs (Ouaaz et al., 2002). Rel B, a
family member involved in alternative NF-κB pathway
signaling, is important in CD8− DC development, al-
though there are inconsistencies between different re-
ports regarding the extent of DC deficiency in these
animals (Castiglioni et al., 2002; Kobayashi et al., 2003;
Wu et al., 1998). The key activators of NF-κB during
DC development and homeostasis have not been well
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cFinally, the in vitro findings with BMDC suggest that
c
in vivo conditions may exist where LTβR signaling pro- f
motes DC maturation. These conditions might include w
(exposure to cells expressing high amounts of LTα1β2,
csuch as activated T cells (Gramaglia et al., 1999), or
sto a combination of LTα1β2 and inflammation-induced
m
cytokines, such as GM-CSF. A requirement for LTβR T
signaling at two different maturation stages of the same a
cell type has been observed previously with follicular a
Gdendritic cells (FDCs) where LTα1β2 is required for de-
velopment of both “immature” FDCs present in primary
Ffollicles and “mature” FDCs present within germinal
F
centers (Cyster et al., 2000). A role for the LTβR in DC C
maturation may explain why CD8+ DCs express the re- C
Lceptor. LTα1β2 is rapidly induced on T cells after TCR
ractivation or exposure to cytokines that engage IL-2Rγ
gchain-containing cytokine receptors, as well as being
P
abundant on Th1 cells (Gramaglia et al., 1999; Luther et j
al., 2002; Ohshima et al., 1999; Ware et al., 1995). Sev- C
eral studies have indicated that T cell responses in lym- m
aphoid tissues are defective in mice where LT function is
(disrupted (Berger et al., 1999; Gommerman et al., 2003;
SKumaraguru et al., 2001). Although this might in part be o
due to reduced DC numbers and disorganization of the b
lymphoid tissue, we speculate that the disrupted T cell w
bresponses are also due to defective T cell-DC com-
bmunication. It has recently been shown that T cell-
sderived LIGHT augments DC maturation and cytokine
e
production (Morel et al., 2001; Scheu et al., 2002). Al-
though most studies have inferred that this occurs via C
engagement of the LIGHT-specific receptor herpes S
avirus entry mediator (HVEM), only one study has dem-
Ponstrated that the effects of LIGHT were antagonized
aby an anti-HVEM antibody (Morel et al., 2001). Because
R
LIGHT is also a ligand for the LTβR, it will be important g
to revisit these studies to determine whether LIGHT P
Aalso acts on DCs via the LTβR. Moreover, because LTαR
Dantagonism ameliorates a variety of T cell inflammatory
Cdisorders, including experimental autoimmune enceph-
p
alomyelitis and diabetes (Gommerman and Browning, p
2003), the possible involvement of DC LTβR signaling A
in disease needs to be investigated. C
p
eExperimental Procedures
BMice, Bone Marrow Chimeras, and Parabiosis
MC57BL/6 (B6), MT (BCR−/−), B6 TCRβ−/−δ−/− (TCR−/−), B6 LTα−/−
3(LTα−/−), B6 LTβ−/− (LTβ−/−), B6 plt/plt, and B6 CD45.1 mice were
sfrom the National Cancer Institutes or a colony maintained at UCSF.
lLTβR−/− mice (Futterer et al., 1998) were kindly provided by Klaus
tPfeffer. Two lines (β4 and β10) of transgenic mice expressing a
btransmembrane bound LTα molecule under control of the Ig κ en-
(hancer and promoter were generated as described (Ngo et al.,
c2001). Bone marrow chimeras were generated as described (Allen
aet al., 2004; Ansel et al., 2002). Parabiotic mice were produced as
tpreviously reported (Ansel et al., 2002) by using 6-week-old male
iB6 and B6 CD45.1 mice that were matched for body weight. Blood
w
exchange was confirmed for all pairs 2 weeks postsurgery by injec-
b
tion of Evan’s blue dye (Ansel et al., 2002).
Cell Preparation S
Spleens, peripheral (axillary, brachial, and inguinal) lymph nodes, S
livers, and lungs were cut into small fragments and digested with w
mixing for 25 min at 37°C in 10 ml RPMI 1640 medium containing 4ollagenase (1.6 mg/ml; type II; Worthington Biochemical, Free-
old, NJ) and DNase I (100 g/ml; Sigma). To disrupt DC-T cell
omplexes, EDTA (200 l, 0.5 M [pH 8.0]) was added, and mixing
ontinued for 5 min. Undigested fibrous material was removed by
iltration through a nylon mesh. All subsequent steps were at 4°C
ith a RPMI 1640 with 4% FBS. BMDC culture was as described
Inaba et al., 1992). In brief, 5 × 106 BM cells were cultured in 10
m tissue culture dishes in 10 ml of medium supplemented with
upernatants from 3T3 cells transfected with the gene-encoding
urine GM-CSF or with 10 ng/ml recombinant GM-CSF (Pepro-
ech) for 5 days. Loosely adherent cells were harvested at day 5
nd incubated at 1 × 106/ml with or without 1 g/ml LTβR agonistic
ntibody (3C8 [Dejardin et al., 2002]) in the presence or absence of
M-CSF and analyzed 1 day later.
low Cytometry and Immunohistochemistry
low cytometry was on a FACSCalibur (BD Biosciences, San Diego,
A), and data were analyzed with FlowJo software (Tree Star, San
arlos, CA). Antibodies used were: biotin-conjugated anti-CD11c,
y6C (HL-3, AL-21; Pharmingen), and DEC205 (NLDC-145; Accu-
ate Chem. Westbury, NY); fluorescein isothiocyanate (FITC)-conju-
ated anti-CD45.2, CD3, Ly6G (Gr-1) (104, 145-2C11, RB6-8C5;
harmingen), and anti-BrdU (Pharmingen); phycoerythrin (PE)-con-
ugated anti-CD11c and anti-CD11b (HL-3; Pharmingen, M1/70.15;
altag); allophycocyanin (APC)-conjugated anti-CD4 (RM4-5; Phar-
ingen) and anti-CD45.2 (104; eBioscience); PerCP-conjugated
nti-CD8 (53-6.7; Pharmingen); and PECy-7 conjugated anti-B220
RA3-6B2; Pharmingen) and anti-NK1.1 (NKR-P1B/C; Pharmingen).
treptavidin-APC was from Molecular Probes. Surface expression
f LTα1β2 was detected with LTβR-Ig (Ansel et al., 2000), followed
y anti-human IgG-PE (Jackson ImmunoResearch). LTβR levels
ere detected by using armenian hamster anti-mouse LTβR anti-
ody (AF.H6; [Mackay et al., 1997]) followed by anti-hamster anti-
ody-PE (Pharmingen). Cryostat sections (7 m) were fixed and
tained with the indicated markers as previously described (Allen
t al., 2004; Ngo et al., 1999).
ell Sorting and Quantitative PCR
pleen cells from B6 mice were stained with anti-CD3-FITC and
nti-CD19-APC for T and B cells, and anti-CD11c-PE, anti-CD8-
erCP, and anti-CD4-APC for DC subsets. Cells were isolated with
MoFlo sorter (Cytomation). The purity of sorted cells are >95%.
NA was prepared from sorted cells or spleen with RNeasy (Qia-
en), and equivalent amounts of cDNA were used for quantitative
CR on an ABI 7700 sequence detection instrument (Taqman; PE
pplied Biosystems) with the following primers/probes (Integrated
NA Technologies): LTβR forward primer 5#-CCAGATGTGAGATC
AGGGC-3#, reverse primer 5#-GACCAGCGACAGCAGGATG-3#,
robe 5#-GACCAGCGACAGCAGGATG-3#; CXCL13 (BLC) forward
rimer 5#-TGGCCAGCTGCCTCTCTC-3#, reverse primer 5#-TTG
AATCACTCCAGAACACCTACA-3#, probe 5#-AGGCCACGGTATT
TGGAAGCCCAT-3#; or for CCL19, CCL21, and hypoxanthine
hosphoribosyl transferase (HPRT) as previously described (Luther
t al., 2000).
rdU Labeling and Cell Cycle Analysis
ice were administered BrdU (2 mg/mouse) intraperitoneally for
.5 hr BrdU pulse. Mice were administered BrdU (2 mg/mouse) in
aline intraperitoneally for the 3.5 hr BrdU pulse. For the 48 hr BrdU
abeling experiments after the BrdU injection, mice were main-
ained on water containing 0.8 mg/ml of BrdU. Splenocytes and
lood leukocytes were prepared and stained with either the ethanol
Allen et al., 2004) or acid technique (Hartley et al., 1993). For cell
ycle analysis, splenocytes were stained with biotin-conjugated
nti-CD11c and anti-CD8-PE, fixed in 1% paraformaldehyde solu-
ion, permeabilized with 0.2% Tween 20 for 15 min at 37°C, and
ncubated with 7-AAD (Pharmingen) for 20 min at 4°C. After staining
ith 7-AAD, the DNA contents were analyzed on the FACSCalibur
y using the doublet discrimination unit.
upplemental Data
upplemental Data include three figures and are available online
ith this article at http://www.immunity.com/cgi/content/full/22/4/
39/DC1/.
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